Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Shoulder Innovations, Inc.NYSE: SI
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures grows 224.4% year over year
Q1 FY2026 capital expenditures of $2.74M (cash outflow) rose 224.4% year over year. Sequentially, it rose 19.9% from the prior quarter.
Context
- Capital expenditures amounted to 15.7% of revenue in FY2025, up 3.0 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 2 fiscal years.
- FY2025 was the largest annual figure in the 3 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (7.41M) USD
- Year-over-year change
- -84.5%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (7.41M) | -84.5% |
| FY2024 | 2024-12-31 | (4.02M) | -46.1% |
| FY2023 | 2023-12-31 | (2.75M) | — |
Capital Expenditures vs competitors
How SI compares with its peers on the latest reported figures
- SI's LTM Mar 2026 capital expenditures of $9.3M is the largest of the 11 companies compared; the peer median is $948.5K.
- Capital expenditures amounts to 17.3% of revenue for SI, versus a peer median of 1.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $9.3M | — | — | 17.3% | |
| LTM Mar 2026 | $9.13M | -39.2% | -21.2% | 2.6% | |
| LTM Dec 2025 | $4.45M | +61.0% | -16.3% | 34.2% | |
| LTM Mar 2026 | $1.77M | -93.4% | +82.4% | 2.6% | |
| LTM Mar 2026 | $1.57M | -7.4% | -18.1% | — | |
| FY2025 | $1.16M | -46.4% | -34.7% | 1.1% | |
| LTM Mar 2026 | $740K | +8.7% | -54.2% | 0.6% | |
EPRXEupraxia Pharmaceuticals Inc. | LTM Mar 2026 | $728.23K | +188.5% | +36.5% | — |
| LTM Mar 2026 | $95K | -8.7% | — | — | |
| LTM Mar 2026 | $85K | +507.1% | -13.5% | 0.1% | |
| LTM Mar 2026 | $73K | +113.6% | — | 0.2% | |
| Peer median (excluding SI) | $948.5K | +0.6% | -17.2% | 1.1% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Net Income | (12.66M) | (15.62M) | (40.36M) |
| Depreciation & Amortization | 1.64M | 2.2M | 3.21M |
| Deferred Income Tax | 0 | 0 | 0 |
| Stock-Based Compensation | 451K | 754K | 996K |
| Change in Working Capital | (4.77M) | (1.04M) | 0 |
| Accounts Receivables | (2.69M) | (575K) | (3.3M) |
| Inventory | (2.41M) | (4.03M) | (7.64M) |
| Accounts Payables | (737K) | 3.12M | 3.37M |
| Other Working Capital | 1.08M | 446K | 0 |
| Other Non-Cash Items | 2.18M | (437K) | 7.54M |
| Operating Cash Flow | (13.14M) | (14.14M) | (28.61M) |
| Capital Expenditures | (2.75M) | (4.02M) | (7.41M) |
| Acquisitions (Net) | 0 | 0 | 0 |
| Purchases of Investments | (29.25M) | (5.28M) | (119.49M) |
| Sales of Investments | 3.03M | 23.26M | 31.3M |
| Other Investing Activities | 0 | 0 | 0 |
| Investing Cash Flow | (28.97M) | 13.96M | (95.6M) |
| Debt Repayment | 10M | 0 | 0 |
| Common Stock Issued | 34.88M | 66K | 39.51M |
| Common Stock Repurchased | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 |
| Other Financing Activities | (149K) | 66K | 144.96M |
| Financing Cash Flow | 44.73M | 66K | 144.96M |
| Effect of Forex Changes | 0 | 0 | 0 |
| Net Change in Cash | 2.61M | (113K) | 20.75M |
| Free Cash Flow | (15.89M) | (18.16M) | (36.02M) |
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.